|
Market Cap (16-May) $64,879,684 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (5-May) 10,361,283 (0.51%) (303rd) |
|
52w High $0.090 |
52w Low $0.031 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 5 June 2023, 8:59. The announcement is marked as price sensitive, and is 3 page(s) in length and 351.24kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.278% short sold according to ASIC data. It was ranked the 388th most shorted stock on the ASX. It is now ranked as the 303rd most shorted stock on the ASX with 0.511% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| First Published Medical Policy from Blue Cross Blue Shield | 5 June 2023, 8:59 |
| Share Purchase Plan Opens | 30 May 2023, 14:12 |
| Notice under section 708A(5)(e) of the Corporations Act | 29 May 2023, 16:06 |
| Update - Application for quotation of securities - IPD | 26 May 2023, 10:09 |
You must be logged in to post a reply.
ImpediMed 